SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000927016-02-001832
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k405.txt 10-K405 217616
3 EMPLOYMENT LETTER WITH ROBERT J. HENNESSEY dex1060.txt EX-10.60 20489
4 LICENSE AND SUPPLY AGREEMENT dex1061.txt EX-10.61 114646
5 CONSENT OF ARTHUR ANDERSEN LLP dex23.txt EX-23 616
6 RISK FACTORS dex991.txt EX-99.1 45970
7 LETTER TO COMMISSION PURSUANT TO TEMP. NOTE 3T dex992.txt EX-99.2 1387
  Complete submission text file 0000927016-02-001832.txt   402917
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K405 | Act: 34 | File No.: 000-10824 | Film No.: 02598009
SIC: 2835 In Vitro & In Vivo Diagnostic Substances